The impact of storage effects in biobanks on biomarker discovery in systems biology studies

Sample handling and storage conditions in specimens frozen over long periods of time can severely impact marker levels. If laboratory technologies, practices and related protocols change over time, biomarker studies are potentially biased and report erroneous results. These issues and pitfalls are often overlooked in system biology studies using previously collected and stored materials, and are likely to be one notable cause for biomarker candidates failing to be validated. We present results from simulation studies quantifying the loss in statistical power to detect true biomarkers, due to diminishing concentration of analytes in samples subject to poor handling and storage conditions.

[1]  H. Meltzer,et al.  The biobank of the Norwegian mother and child cohort Study: A resource for the next 100 years , 2006, European Journal of Epidemiology.

[2]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[3]  M S Pepe,et al.  Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.

[4]  R. Vyzula,et al.  Surface-enhanced laser desorption ionization/time-of-flight mass spectrometry reveals significant artifacts in serum obtained from clot activator-containing collection devices. , 2006, Clinical chemistry.

[5]  Gordon Whiteley,et al.  Bringing diagnostic technologies to the clinical laboratory: Rigor, regulation, and reality , 2008, Proteomics. Clinical applications.

[6]  Eva M. L. Smets,et al.  Influence of blood collection in plastic vs. glass evacuated serum-separator tubes on hormone and tumour marker levels , 2004, Clinical chemistry and laboratory medicine.

[7]  G. Hortin,et al.  Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides. , 2004, Clinical chemistry.

[8]  J. van der Greef,et al.  The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.

[9]  T. Peakman,et al.  Design and implementation of a high-throughput biological sample processing facility using modern manufacturing principles. , 2008, International journal of epidemiology.

[10]  P. Elliott,et al.  The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. , 2008, International journal of epidemiology.

[11]  G. Lippi,et al.  Interference of blood cell lysis on routine coagulation testing. , 2006, Archives of pathology & laboratory medicine.

[12]  E. Diamandis.  Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool , 2004, Molecular & Cellular Proteomics.

[13]  G. Lippi,et al.  Influence of short-term venous stasis on clinical chemistry testing , 2005, Clinical chemistry and laboratory medicine.

[14]  Graham B. I. Scott,et al.  HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples , 2005, Proteomics.

[15]  Jeffrey S. Morris,et al.  The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. , 2005, Briefings in functional genomics & proteomics.

[16]  Nils Brünner,et al.  Banking of Biological Fluids for Studies of Disease-associated Protein Biomarkers* , 2008, Molecular & Cellular Proteomics.

[17]  Silke von Ahlfen,et al.  Determinants of RNA Quality from FFPE Samples , 2007, PloS one.

[18]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Yu Guo,et al.  Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms , 2010, BMC Bioinformatics.

[20]  Richard D. Kennedy,et al.  RNA expression analysis from formalin fixed paraffin embedded tissues , 2008, Histochemistry and Cell Biology.

[21]  E. Diamandis.  Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. , 2004, Journal of the National Cancer Institute.

[22]  E. Petricoin,et al.  Putting the "bio" back into biomarkers: orienting proteomic discovery toward biology and away from the measurement platform. , 2008, Clinical chemistry.

[23]  J. Barrett,et al.  Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. , 2005, Clinical chemistry.

[24]  B. Zetter,et al.  Cancer biomarkers: knowing the present and predicting the future. , 2005, Future oncology.

[25]  Laura K. Schnackenberg,et al.  The Liver Toxicity Biomarker Study: Phase I Design and Preliminary Results , 2009, Toxicologic pathology.

[26]  R. Laessig,et al.  Comparison of plastic vs. glass evacuated serum-separator (SST) blood-drawing tubes for common clinical chemistry determinations. , 1992, Clinical chemistry.